# A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)

> **NCT01600339** · PHASE2 · COMPLETED · sponsor: **Rambam Health Care Campus** · enrollment: 19 (actual)

## Conditions studied

- Urothelial Carcinoma

## Interventions

- **DRUG:** CABAZITAXEL

## Key facts

- **NCT ID:** NCT01600339
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2015-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01600339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01600339, "A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01600339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*